News.

Press releases and featured media

In the Media 2 mins
June 05, 2023

The Path to Automation in the Clinical Laboratory

As clinical labs face a slew of workflow challenges—including personnel shortages and increasing pressure to reduce costs—automation is making a strong case for adoption. This technology’s affinity for completing otherwise tedious, repetitive tasks means that lab technologists and clinicians can spend more time making critical and better-informed decisions, some of which may lead to life-changing and life-saving results for patients.
Link to full article
In the Media 4 mins
October 27, 2022

Creative Destruction: The Rise of Digital Innovations in Clinical Laboratories

Digital innovations are shifting the role of laboratory medicine from “a hidden champion that saves lives” toward a higher visibility representing a new paradigm in standard of care.
Link to full article
In the Media 3 mins
September 26, 2022

Digitizing Blood Tests For Faster Analysis

Scopio Labs built a high-speed scanner that digitizes the process of analyzing blood samples for faster results aided by AI. In the 21st century, says Scopio Labs CEO Itai Hayut, there’s no reason for a lab technician to be analyzing blood samples manually under a microscope.
Link to full article
Press Releases 5 mins
September 08, 2022

Scopio Labs Launches World’s First Digital Application for Bone Marrow Aspirate Imaging and Review

Scopio Labs, developer of Full-Field Cell Morphology™ imaging and AI-powered analysis platforms to support laboratory professionals in the detection of cancers, anemia, infections, and other blood-related diseases, announced today the launch of the Full-Field Bone Marrow Aspirate™ (FF-BMA) Application. This platform is the first to enable a complete digital workflow for bone marrow aspirate scanning and analysis.
Read more
In the Media 4 mins
August 30, 2022

Beckman Coulter and Scopio Labs partnership brings innovative digital solution to the hematology lab

In this video, Beckman Coulter and Scopio Labs announce their exciting new partnership. Listen to Peter Soltani, Senior Vice President at Beckman Coulter, and Itai Hayut, Co-founder and CEO, Scopio Labs describe this newly developed AI-powered workflow solution for hematology labs. This innovative technology addresses many of the pain points in labs today, scanning and digitizing microscopy slides and providing a complete digital solution to hematology laboratories.
Link to full article
In the Media 1 min
August 02, 2022

Beckman Coulter and Scopio Labs accelerate adoption of hematology digital cell morphology platform

Beckman Coulter and Scopio Labs have announced a worldwide partnership to accelerate adoption of Scopio’s next generation peripheral blood smear platforms. Using AI, Scopio have developed scanners which image the entire blood sample at 100x magnification to truly eliminate manual microscopy and allow for the complete remote analysis of scans.
Link to full article
Press Releases 3 mins
July 20, 2022

Beckman Coulter and Scopio Labs Partner to Accelerate Adoption of Hematology Digital Cell Morphology Platform

Beckman Coulter, a global leader in clinical diagnostics, and Scopio Labs, a medtech company that develops AI-powered workflow solutions, announced today a worldwide partnership to accelerate adoption of Scopio’s next generation peripheral blood smear platforms.
Read more
In the Media 2 mins
June 20, 2022

Replacing microscopes with digitization

Scopio Labs, a medtech company that develops AI-powered diagnostic platforms for earlier and more accurate detection of cancers, infections, and other diseases, has announced that its ground-breaking X100HT device with Peripheral Blood Smear (PBS) Application has received US FDA 510(k) clearance. Coupling high throughput capabilities with the highest resolution for hematological analysis, the X100HT caters to major medical facilities and labs across the world.
Link to full article
In the Media 1 min
June 17, 2022

FDA clears Scopio Labs digital cell morphology platform

Scopio Labs received FDA 510(k) clearance for its X100HT hematology digital cell morphology platform with peripheral blood smear review.
Link to full article
In the Media 1 min
June 12, 2022

Scopio Labs Gets FDA Clearance For Blood Smear Device

Israeli digital microscopy company Scopio Labs, announced this week that it has received US FDA 510(k) clearance for its X100HT device with Full-Field Peripheral Blood Smear (PBS) Application to improve the accuracy and speed of hematological tests.
Link to full article

Experience high resolution digital imaging and AI-driven full-field analysis

Book a demo